Boston Scientific Corp.

Marlborough medical device company Boston Scientific has received U.S. Food and Drug Administration approval for its TheraSphere Y-90 Glass Microspheres cancer treatment.

Marlborough medical device company Boston Scientific announced Wednesday that it has entered into an agreement to acquire the global surgical business of Lumenis LTD.

Marlborough's Boston Scientific and Worcester's Hanover Insurance Group are among 767 companies nationwide lauded for LGBTQ equality.

Marlborough medical device company Boston Scientific reported a net sales decline of $822 million in 2020, with losses across the board accounting for a 7.7% drop from 2019’s sales.

Marlborough medical device company Boston Scientific’s fourth generation Vercise Genus Deep Brain Stimulation System has received FDA approval, the company announced on Friday.

Marlborough medical device manufacturer Boston Scientific has entered into an agreement to purchase a Minnesota mobile cardiac health company for up to $1.2 billion, although due to stock ownership the final price is likely to be closer to $275 million.

Boston Scientific reported an $830 million decline in net sales for 2020 compared to the previous year.

Marlborough medical device manufacturer Boston Scientific Corp. has announced a limited market release of a new pain-relief system that uses electrical impulses in the spine to block pain signals.

Boston Scientific in Marlborough is among a rising number of big corporations that are temporarily stopping political donations, a trend that has followed a riot at the U.S. Capitol that was fueled by President Donald Trump.

For a short stretch early on when the coronavirus pandemic began spreading, the American stock market took a nosedive. In almost all the time since, the stock market, including most of the largest public companies in Central Massachusetts, spent 2020 recovering — and then some.